Innovative Pharmaceutical Biotech Limited announced unaudited consolidated financial results for the six months ended 30 September 2020. For the period, the company reported revenue of HKD 7,152,000 against HKD 11,126,000 a year ago. Loss for the period was HKD 94,207,000 against HKD 111,296,000 a year ago. Loss per share Basic and diluted were 6.38 cents against 7.55 cents a year ago.